Management of Uncontrolled Hypertension

Assessment and Treatment

For a patient with uncontrolled hypertension on an ACE inhibitor, the American Heart Association recommends adding a dihydropyridine calcium channel blocker (DHP-CCB) to the treatment regimen, as this combination provides complementary mechanisms of action and has demonstrated superior efficacy compared to ACE inhibitor monotherapy 1, 2
The European Society of Cardiology guidelines recommend a RAS blocker (ACE inhibitor) plus a DHP-CCB as a preferred combination for hypertension management, particularly for elderly patients 2
The American College of Cardiology recommends starting with lower doses of added medication and titrating gradually to minimize adverse effects in elderly patients 1

Adding a DHP-CCB such as amlodipine 5-10 mg daily to an ACE inhibitor is recommended as a first-line addition for patients with uncontrolled hypertension, as it provides significant additional BP reduction 1, 2
The combination of amlodipine and an ACE inhibitor has demonstrated mean BP reductions of 17/14 mmHg, compared to 5/7 mmHg with ACE inhibitor monotherapy 2

The European Society of Hypertension recommends reassessing blood pressure within 2-4 weeks after medication addition and targeting a systolic BP <140 mmHg in elderly patients 1, 3
Monitoring for potential adverse effects, such as peripheral edema, headache, and flushing with DHP-CCB, and electrolyte disturbances with diuretics, is recommended 1

Fixed-dose combination pills should be considered to improve medication adherence in elderly patients, according to the European Heart Journal 2
Checking orthostatic blood pressure measurements to assess for postural hypotension is recommended in elderly patients 3

Adding a thiazide or thiazide-like diuretic is an alternative first-line combination option for patients with uncontrolled hypertension, particularly in volume-dependent hypertension common in elderly patients 1, 4

Progressing to a three-drug regimen by adding a thiazide-like diuretic if not already included is recommended if BP remains uncontrolled after a two-drug combination 1, 2
Adding spironolactone as a fourth agent may be considered if BP remains uncontrolled on a three-drug regimen 2, 3

Combining two RAS blockers should be avoided, as it increases adverse effects without significant benefit, according to the European Heart Journal 2
Rapid BP lowering in elderly patients should be avoided, as it may lead to orthostatic hypotension and falls 3